Two unique handheld devices from a Welsh company that monitor the blood clotting status of patients are set for launch in the US.
The CoagMax (pictured) and CoagLite devices from Microvisk Technologies are a point of care test (for clinicians) and a home test (for patients) respectively to set the correct dosage of the anti-coagulation drug Warfarin.
The Microvisk devices, which have attracted strong interest from US distributors, are set to be trialled with 250 patients in Florida from October, with product launches scheduled for mid-2012.
In both devices a single-use SmartStrip with embedded sensors and a memory chip measures the clotting speed of blood from a fingerprick drop, and the results are displayed on a handheld reader.
The SmartStrip is based on Micro-Electro-Mechanical System (MEMS) technology, used in the iPhone and Nintendo Wii. This provides a more accurate result from a smaller blood sample than existing devices.
Multi-centre clinical trials of CoagMax and CoagLite are under way in the UK and Germany, where product launches are scheduled for early 2012. The devices will be showcased at Medica 2011 in November.
John Curtis, CEO of Microvisk, said: “We are delighted at the overwhelming interest shown by US distributors and potential partners in our CoagMax and CoagLite devices. We have been expanding our UK manufacturing facilities and are recruiting additional staff as we prepare for European product launches in early 2012.”
Microvisk has established a US operation in Florida. Bill Moffitt, the company’s US Chairman, commented: “These innovative devices will transform the way that blood testing is carried out, and Microvisk now has the opportunity to capture a substantial share of the market for doctor’s office and home tests for Warfarin patients.”
Over a million new patients each year use Warfarin to treat blood clotting disorders. They currently need regular blood tests at a surgery or clinic – but the Microvisk devices will enable them to test their blood clotting at home.
Based at St Asaph Business Park in North Wales, Microvisk specialises in medical testing devices based on MEMS technology.